"Colitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Descriptor ID |
D003092
|
| MeSH Number(s) |
C06.405.205.265 C06.405.469.158.188
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Colitis".
Below are MeSH descriptors whose meaning is more specific than "Colitis".
This graph shows the total number of publications written about "Colitis" by people in this website by year, and whether "Colitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 2 | 2 | 4 |
| 2008 | 1 | 0 | 1 |
| 2009 | 3 | 1 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 4 | 1 | 5 |
| 2012 | 4 | 1 | 5 |
| 2013 | 4 | 2 | 6 |
| 2014 | 4 | 1 | 5 |
| 2015 | 8 | 1 | 9 |
| 2016 | 4 | 1 | 5 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 1 | 2 |
| 2020 | 7 | 0 | 7 |
| 2021 | 9 | 4 | 13 |
| 2022 | 9 | 0 | 9 |
| 2023 | 5 | 0 | 5 |
| 2024 | 3 | 1 | 4 |
| 2025 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colitis" by people in Profiles.
-
Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation. J Exp Med. 2025 Nov 03; 222(11).
-
Disease Outcomes in Immune-Mediated Colitis: A Study Describing Initial Endoscopic and Histologic Presentations and Treatment Options. J Natl Compr Canc Netw. 2025 Sep; 23(9).
-
Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis. Cancer Med. 2025 Aug; 14(15):e71123.
-
Microbial Biosensor for Sensing and Treatment of Intestinal Inflammation. Adv Sci (Weinh). 2025 Jul; 12(27):e2504364.
-
Differential Disease Behavior of Immune-Mediated Colitis Among Different Types of Immune Checkpoint Inhibition. Target Oncol. 2025 Mar; 20(2):339-347.
-
Immune checkpoint inhibitor-induced diarrhea and colitis: an overview. Support Care Cancer. 2024 Sep 23; 32(10):680.
-
HIF-2a-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis. Nat Commun. 2024 09 14; 15(1):8042.
-
Toxicity in the era of immune checkpoint inhibitor therapy. Front Immunol. 2024; 15:1447021.
-
NF-?B Inducing Kinase Attenuates Colorectal Cancer by Regulating Noncanonical NF-?B Mediated Colonic Epithelial Cell Regeneration. Cell Mol Gastroenterol Hepatol. 2024; 18(3):101356.
-
Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis. J Exp Med. 2024 Jun 03; 221(6).